In focus · trending topic

CDMO

36 stories · following the connections

Avid Bioservices Announces Appointment of Magnus Schroeder, Ph.D., as Vice President of Process Sciences

By Nasdaq OMXMay 8, 2018, 12:05 PM UTC

Avid Bioservices Receives Six 2018 CMO Leadership Awards

By Nasdaq OMXMar 22, 2018, 12:05 PM UTC

PCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San Diego

By Nasdaq OMXFeb 27, 2018, 2:15 PM UTC

Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant Sciences

By Nasdaq OMXFeb 21, 2018, 1:05 PM UTC

PCI Synthesis Submits Patent for Synthesizing Azelaic Acid

By Nasdaq OMXJan 30, 2018, 2:15 PM UTC

Avid Bioservices to Present at NobleCon14

By Nasdaq OMXJan 23, 2018, 1:05 PM UTC

PCI Synthesis’ Ed Price Joins SOCMA’s Board of Governors

By Nasdaq OMXJan 11, 2018, 2:15 PM UTC

Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)

By Nasdaq OMXJan 5, 2018, 1:05 PM UTC